VEGF and ANG-2 — Drug Target

1 drugs 1 in Phase 3

All drugs that target VEGF and ANG-2 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Bispecific antibody

Phase 3 pipeline (1)